Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HLA-A2 Antigen | 8 | 2021 | 172 | 1.260 |
Why?
|
| Caspase 9 | 1 | 2014 | 187 | 0.440 |
Why?
|
| T-Lymphocytes, Cytotoxic | 8 | 2021 | 1020 | 0.410 |
Why?
|
| Transgenes | 1 | 2014 | 576 | 0.400 |
Why?
|
| Bacillus subtilis | 5 | 1996 | 56 | 0.380 |
Why?
|
| T-Lymphocytes | 4 | 2019 | 3949 | 0.380 |
Why?
|
| Antigens, Neoplasm | 5 | 2019 | 1580 | 0.320 |
Why?
|
| Myeloblastin | 4 | 2012 | 65 | 0.300 |
Why?
|
| Leukocyte Elastase | 3 | 2012 | 71 | 0.300 |
Why?
|
| Leukemia, Myeloid, Acute | 5 | 2021 | 7265 | 0.300 |
Why?
|
| Spores, Bacterial | 5 | 1996 | 46 | 0.290 |
Why?
|
| Peptides | 4 | 2021 | 1504 | 0.220 |
Why?
|
| Gene Expression Regulation, Bacterial | 3 | 1994 | 205 | 0.210 |
Why?
|
| Sigma Factor | 5 | 1996 | 43 | 0.210 |
Why?
|
| Cytotoxicity, Immunologic | 6 | 2019 | 683 | 0.200 |
Why?
|
| Peroxidase | 1 | 2021 | 133 | 0.180 |
Why?
|
| Immunity, Cellular | 1 | 2002 | 440 | 0.180 |
Why?
|
| Peptide Fragments | 3 | 2018 | 1309 | 0.180 |
Why?
|
| Leukemia | 2 | 2012 | 1719 | 0.180 |
Why?
|
| Cross-Priming | 3 | 2018 | 40 | 0.170 |
Why?
|
| Lymphocyte Activation | 4 | 2019 | 1723 | 0.160 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 896 | 0.160 |
Why?
|
| Mice, SCID | 2 | 2021 | 1826 | 0.160 |
Why?
|
| Bacterial Proteins | 3 | 1995 | 1092 | 0.160 |
Why?
|
| Protein Precursors | 3 | 1996 | 249 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 714 | 0.150 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | 2010 | 2635 | 0.150 |
Why?
|
| Cancer Vaccines | 1 | 2004 | 754 | 0.150 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2014 | 7044 | 0.140 |
Why?
|
| Dictyostelium | 4 | 2004 | 126 | 0.140 |
Why?
|
| Androgens | 1 | 1999 | 506 | 0.140 |
Why?
|
| Cell Division | 1 | 1999 | 2657 | 0.120 |
Why?
|
| Antibodies, Bispecific | 1 | 2019 | 282 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 3 | 1996 | 809 | 0.120 |
Why?
|
| Endopeptidases | 1 | 1995 | 230 | 0.110 |
Why?
|
| Cathepsin G | 1 | 2012 | 22 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2004 | 240 | 0.110 |
Why?
|
| Epitopes | 2 | 2012 | 707 | 0.100 |
Why?
|
| Cell Communication | 1 | 1994 | 512 | 0.100 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2011 | 115 | 0.090 |
Why?
|
| Transcription Factors | 3 | 1996 | 5438 | 0.090 |
Why?
|
| Complement System Proteins | 1 | 2011 | 135 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 401 | 0.080 |
Why?
|
| Antigen-Presenting Cells | 3 | 2018 | 286 | 0.080 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2009 | 73 | 0.080 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2009 | 219 | 0.080 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2018 | 1335 | 0.080 |
Why?
|
| Mice | 7 | 2021 | 35600 | 0.080 |
Why?
|
| Animals | 13 | 2021 | 61956 | 0.080 |
Why?
|
| Interferon-alpha | 2 | 2010 | 959 | 0.070 |
Why?
|
| Interleukin-17 | 1 | 2009 | 255 | 0.070 |
Why?
|
| Cyclic AMP | 3 | 2004 | 378 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2011 | 1137 | 0.070 |
Why?
|
| Receptors, Immunologic | 1 | 2009 | 313 | 0.070 |
Why?
|
| Immunotherapy | 3 | 2012 | 3557 | 0.070 |
Why?
|
| Immune Tolerance | 1 | 2009 | 427 | 0.070 |
Why?
|
| Leukemia, Myeloid | 1 | 2011 | 993 | 0.070 |
Why?
|
| Multiple Myeloma | 1 | 2018 | 2328 | 0.070 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2019 | 1840 | 0.060 |
Why?
|
| Contractile Proteins | 1 | 2004 | 44 | 0.060 |
Why?
|
| Humans | 16 | 2021 | 270740 | 0.060 |
Why?
|
| Chemotaxis | 2 | 2004 | 136 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 1995 | 2928 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2009 | 1051 | 0.060 |
Why?
|
| Protozoan Proteins | 2 | 2004 | 123 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 295 | 0.050 |
Why?
|
| Amino Acid Sequence | 5 | 2012 | 4567 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 2351 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 1999 | 5866 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2018 | 593 | 0.050 |
Why?
|
| Protein Binding | 3 | 2019 | 3485 | 0.050 |
Why?
|
| Genes, Bacterial | 3 | 1996 | 270 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2004 | 494 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2009 | 1655 | 0.050 |
Why?
|
| Recombinant Proteins | 3 | 1998 | 3028 | 0.050 |
Why?
|
| Plasmids | 2 | 1995 | 936 | 0.050 |
Why?
|
| Pseudopodia | 1 | 2000 | 26 | 0.050 |
Why?
|
| Protein Transport | 2 | 2012 | 737 | 0.040 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1999 | 248 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 1999 | 206 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2012 | 5759 | 0.040 |
Why?
|
| Cricetulus | 1 | 2019 | 214 | 0.040 |
Why?
|
| CHO Cells | 1 | 2019 | 320 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2019 | 336 | 0.040 |
Why?
|
| Signal Transduction | 5 | 2012 | 12103 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1999 | 537 | 0.040 |
Why?
|
| Cell Line, Tumor | 4 | 2018 | 14849 | 0.040 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1999 | 319 | 0.040 |
Why?
|
| Cyclins | 1 | 1999 | 467 | 0.040 |
Why?
|
| Melanoma | 2 | 2012 | 5595 | 0.040 |
Why?
|
| Complement Activation | 1 | 2018 | 93 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2012 | 16215 | 0.040 |
Why?
|
| Cell Line | 2 | 2019 | 5338 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 2018 | 286 | 0.040 |
Why?
|
| Biological Transport | 1 | 2018 | 626 | 0.030 |
Why?
|
| Molecular Sequence Data | 4 | 2012 | 6685 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2004 | 631 | 0.030 |
Why?
|
| Escherichia coli | 2 | 1995 | 1305 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2018 | 255 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2004 | 2098 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2012 | 4895 | 0.030 |
Why?
|
| Transplantation, Homologous | 2 | 2012 | 3046 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 2454 | 0.030 |
Why?
|
| Dendritic Cells | 2 | 2012 | 1110 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1998 | 470 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 1999 | 854 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2018 | 672 | 0.030 |
Why?
|
| Protein Kinases | 1 | 1998 | 902 | 0.030 |
Why?
|
| Morphogenesis | 1 | 1995 | 319 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 1996 | 607 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 3844 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2010 | 3045 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1999 | 1542 | 0.030 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 2 | 2004 | 38 | 0.030 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2012 | 149 | 0.030 |
Why?
|
| Male | 4 | 2014 | 128315 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 1999 | 1942 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2004 | 3584 | 0.020 |
Why?
|
| Female | 5 | 2014 | 148940 | 0.020 |
Why?
|
| Adenylyl Cyclases | 2 | 2004 | 103 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 7381 | 0.020 |
Why?
|
| Gene Expression | 1 | 1999 | 3640 | 0.020 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2011 | 107 | 0.020 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2012 | 247 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2012 | 640 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2011 | 116 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1990 | 340 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 345 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2011 | 228 | 0.020 |
Why?
|
| Genes, Protozoan | 2 | 2000 | 32 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 1496 | 0.020 |
Why?
|
| Lysosomes | 1 | 2012 | 345 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2009 | 5728 | 0.020 |
Why?
|
| Base Sequence | 2 | 2012 | 5437 | 0.020 |
Why?
|
| Antibodies | 1 | 2012 | 809 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2012 | 579 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3917 | 0.020 |
Why?
|
| Antibody Affinity | 1 | 2009 | 61 | 0.020 |
Why?
|
| Apoptosis | 2 | 2003 | 7757 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2009 | 95 | 0.020 |
Why?
|
| Leukocytes | 1 | 2011 | 421 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2010 | 574 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2011 | 1246 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 1054 | 0.020 |
Why?
|
| Kinetics | 1 | 1990 | 2220 | 0.020 |
Why?
|
| Computer Simulation | 2 | 2004 | 1570 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 12033 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2011 | 1275 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2009 | 1028 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2010 | 1179 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 1424 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2012 | 1367 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 3597 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2010 | 1726 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2009 | 889 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2009 | 436 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2004 | 1642 | 0.020 |
Why?
|
| Filamins | 1 | 2004 | 33 | 0.020 |
Why?
|
| Receptors, Cyclic AMP | 1 | 2004 | 4 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 175 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 210 | 0.010 |
Why?
|
| Tumor Burden | 1 | 2010 | 2033 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2004 | 453 | 0.010 |
Why?
|
| Stem Cells | 1 | 2011 | 1216 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 2009 | 4481 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2004 | 338 | 0.010 |
Why?
|
| Remission Induction | 1 | 2010 | 3656 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2004 | 726 | 0.010 |
Why?
|
| Light | 1 | 2004 | 279 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2004 | 589 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 4252 | 0.010 |
Why?
|
| Genome, Human | 1 | 2011 | 1888 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 938 | 0.010 |
Why?
|
| Cell Movement | 1 | 2010 | 2472 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2004 | 1082 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2010 | 2441 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2004 | 693 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 2399 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 5694 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 768 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2003 | 275 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 6256 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2004 | 1254 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 1525 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 1472 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 4223 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2004 | 878 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 7655 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 2000 | 69 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 2000 | 61 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 1810 | 0.010 |
Why?
|
| Myosins | 1 | 2000 | 97 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2011 | 2810 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 4644 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2004 | 1474 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 9470 | 0.010 |
Why?
|
| RNA, Protozoan | 1 | 1998 | 13 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 2422 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 7100 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 5776 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 5056 | 0.010 |
Why?
|
| Thiosulfate Sulfurtransferase | 1 | 1996 | 4 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1998 | 876 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2004 | 4942 | 0.010 |
Why?
|
| Models, Biological | 1 | 2004 | 3194 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1998 | 662 | 0.010 |
Why?
|
| Adult | 2 | 2011 | 82040 | 0.010 |
Why?
|
| Cattle | 1 | 1996 | 833 | 0.010 |
Why?
|
| Middle Aged | 2 | 2011 | 90352 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 22251 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1998 | 1281 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1998 | 2137 | 0.010 |
Why?
|
| Mutation | 2 | 2004 | 15912 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 33737 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 1990 | 494 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1998 | 6390 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 1998 | 4130 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1990 | 1655 | 0.000 |
Why?
|
| Aged | 1 | 2011 | 73333 | 0.000 |
Why?
|
| DNA Mutational Analysis | 1 | 1990 | 2357 | 0.000 |
Why?
|
| Phenotype | 1 | 1990 | 6509 | 0.000 |
Why?
|